Neonatal invasive candidiasis in low- and middle-income countries: Data from the NeoOBS study
Aislinn Cook,Laura Ferreras-Antolin,Bethou Adhisivam,Daynia Ballot,James A Berkley,Paola Bernaschi,Cristina G Carvalheiro,Napaporn Chaikittisuk,Yunsheng Chen,Vindana Chibabhai,Shweta Chitkara,Sara Chiurchiu,Elisavet Chorafa,Tran Minh Dien,Angela Dramowski,Samantha Faria de Matos,Jinxing Feng,Daniel Jarovsky,Ravinder Kaur,Warunee Khamjakkaew,Premsak Laoyookhong,Edwin Machanja,Marisa M Mussi-Pinhata,Flavia Namiiro,Gita Natraj,Hakka Naziat,Hoang Thi Bich Ngoc,Claude Ondongo-Ezhet,Kanchana Preedisripipat,Hafizur Rahman,Amy Riddell,Emmanuel Roilides,Neal Russell,Apurba S Sastry,Hannington Baluku Tasimwa,Ji Tongzhen,Jeannette Wadula,Yajuan Wang,Andrew Whitelaw,Dan Wu,Varsha Yadav,Gao Yang,Wolfgang Stohr,Julia Anna Bielicki,Sally Ellis,Adilia Warris,Paul T Heath,Michael Sharland
DOI: https://doi.org/10.1093/mmy/myad010
IF: 3.747
2023-03-01
Medical Mycology
Abstract:Abstract Neonatal invasive candidiasis (NIC) has significant morbidity and mortality. Reports have shown a different profile of those neonates affected with NIC and of fluconazole-resistant Candida spp. isolates in low- and middle-income countries (LMICs) compared to high-income countries (HICs). We describe the epidemiology, Candida spp. distribution, treatment, and outcomes of neonates with NIC from LMICs enrolled in a global, prospective, longitudinal, observational cohort study (NeoOBS) of hospitalized infants <60 days postnatal age with sepsis (August 2018–February 2021). A total of 127 neonates from 14 hospitals in 8 countries with Candida spp. isolated from blood culture were included. Median gestational age of affected neonates was 30 weeks (IQR: 28–34), and median birth weight was 1270 gr (interquartile range [IQR]: 990–1692). Only a minority had high-risk criteria, such as being born <28 weeks, 19% (24/127), or birth weight <1000 gr, 27% (34/127). The most common Candida species were C. albicans (n = 45, 35%), C. parapsilosis (n = 38, 30%), and Candida auris (n = 18, 14%). The majority of C. albicans isolates were fluconazole susceptible, whereas 59% of C. parapsilosis isolates were fluconazole-resistant. Amphotericin B was the most common antifungal used [74% (78/105)], followed by fluconazole [22% (23/105)]. Death by day 28 post-enrollment was 22% (28/127). To our knowledge, this is the largest multi-country cohort of NIC in LMICs. Most of the neonates would not have been considered at high risk for NIC in HICs. A substantial proportion of isolates was resistant to first choice fluconazole. Understanding the burden of NIC in LMIC is essential to guide future research and treatment guidelines.
infectious diseases,veterinary sciences,mycology